EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells

Shaochen Qin, Xiaobo Wan, Shanshan Kong, Kunmei Xu, Jungong Jin, Shiming He, Mingsheng Chen iD

Journal of Neurophysiology · 2025

DOI: 10.1152/jn.00351.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurophysiology, 2025. Verfasst von Shaochen Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Hospital Affiliated to Shanxi University of Chinese Medicine, Taiyuan, People's Republic of China. Hauptthemen laut MEDLINE: Oxidopamine, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, Quercetin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: national regional medical center of traditional Chinese medicine of Chin, Health Commission of Shanxi Province ().

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isorhamnetin (Iso) ameliorated neuronal activity damage, senescence, apoptosis, and oxidative stress injury in 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y cells. Iso activated AKT/mTOR signaling pathway via inhibiting Fos-like antigen (FOSL1) in 6-OHDA-induced SH-SY5Y cells. Overexpression of FOSL1 attenuated the protective effect of Iso against 6-OHDA-induced neuronal damage in SH-SY5Y cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxidopamineProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesQuercetinDopaminergic NeuronsProto-Oncogene Proteins c-fosHumansCell Line, TumorApoptosisNeuroprotective AgentsSignal TransductionOxidative StressFos-Related Antigen 1

Stichwörter der Autor:innen

FOSL1Parkinson’s diseaseSH-SY5Yisorhamnetinoxidative stress

Substanzen

OxidopamineProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesQuercetinProto-Oncogene Proteins c-fosNeuroprotective AgentsFos-Related Antigen 13-methylquercetinMTOR protein, human

Autor:innen und Institutionen

  • Department of Neurology, The Hospital Affiliated to Shanxi University of Chinese Medicine, Taiyuan, People's Republic of China.
  • Department of Acupuncture and moxibustion, The Hospital Affiliated to Shanxi University of Chinese Medicine, Taiyuan, People's Republic of China.
  • Department of Neurosurgery, Xi'an International Medical Center Hospital, Xi'an, People's Republic of China.

ORCID-Profile: Mingsheng Chen

Förderung

  • national regional medical center of traditional Chinese medicine of Chin
  • Health Commission of Shanxi Province ()

Zitieren

APA

Qin, S., Wan, X., Kong, S., Xu, K., Jin, J., He, S., & Chen, M. (2025). Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells. Journal of Neurophysiology. https://doi.org/10.1152/jn.00351.2024

Vancouver

Qin S, Wan X, Kong S, Xu K, Jin J, He S, et al. Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells. Journal of Neurophysiology. 2025. doi:10.1152/jn.00351.2024

BibTeX
@article{Qin2025,
  author = {Qin, Shaochen and Wan, Xiaobo and Kong, Shanshan and Xu, Kunmei and Jin, Jungong and He, Shiming and Chen, Mingsheng},
  title = {Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells},
  journal = {Journal of Neurophysiology},
  year = {2025},
  doi = {10.1152/jn.00351.2024}
}
Kostenlos starten →